The Design and Development of a Multi-HBV Antigen Encoded in Chimpanzee Adenoviral and Modified Vaccinia Ankara Viral Vectors; A Novel Therapeutic Vaccine Strategy against HBV

Chronic hepatitis B virus (HBV) infection affects 257 million people globally. Current therapies suppress HBV but viral rebound occurs on cessation of therapy; novel therapeutic strategies are urgently required. To develop a therapeutic HBV vaccine that can induce high magnitude T cells to all major...

Descripción completa

Detalles Bibliográficos
Autores principales: Chinnakannan, Senthil K., Cargill, Tamsin N., Donnison, Timothy A., Ansari, M. Azim, Sebastian, Sarah, Lee, Lian Ni, Hutchings, Claire, Klenerman, Paul, Maini, Mala K., Evans, Tom, Barnes, Eleanor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348829/
https://www.ncbi.nlm.nih.gov/pubmed/32295168
http://dx.doi.org/10.3390/vaccines8020184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348829/
https://www.ncbi.nlm.nih.gov/pubmed/32295168
http://dx.doi.org/10.3390/vaccines8020184

Ejemplares similares